Grove Bank & Trust Zoetis Inc. Transaction History

Grove Bank & Trust

$622 Million
Q2 2024

A detailed history of Grove Bank & Trust transactions in Zoetis Inc. stock. As of the latest transaction made, Grove Bank & Trust holds 11,702 shares of ZTS stock, worth $2.19 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

11,702

Previous 8,381 39.63%

Holding current value

$2.19 Million

Previous $1.42 Million 43.02%

% of portfolio

0.33%

Previous 0.24%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$145.54 - $178.83 $483,338 - $593,894	3,321 Added 39.63%	11,702 $2.03 Million
Q1 2024 Apr 30, 2024	BUY	$165.67 - $199.94 $66,268 - $79,976	400 Added 5.01%	8,381 $1.42 Million
Q4 2023 Jan 30, 2024	BUY	$151.44 - $200.09 $66,482 - $87,839	439 Added 5.82%	7,981 $1.58 Million
Q3 2023 Oct 30, 2023	BUY	$167.14 - $192.77 $130,870 - $150,938	783 Added 11.58%	7,542 $1.31 Million
Q2 2023 Jul 27, 2023	BUY	$160.94 - $186.23 $56,168 - $64,994	349 Added 5.44%	6,759 $1.16 Million
Q1 2023 May 10, 2023	SELL	$145.48 - $175.02 $1,309 - $1,575	-9 Reduced 0.14%	6,410 $1.07 Million
Q4 2022 Feb 03, 2023	SELL	$131.14 - $157.47 $43,013 - $51,650	-328 Reduced 4.86%	6,419 $941,000
Q3 2022 Oct 28, 2022	BUY	$148.29 - $182.55 $3,262 - $4,016	22 Added 0.33%	6,747 $1 Million
Q2 2022 Jul 29, 2022	SELL	$155.97 - $200.09 $72,682 - $93,241	-466 Reduced 6.48%	6,725 $1.16 Million
Q1 2022 Apr 22, 2022	SELL	$181.39 - $234.03 $31,199 - $40,253	-172 Reduced 2.34%	7,191 $1.36 Million
Q4 2021 Jan 31, 2022	BUY	$193.69 - $247.03 $82,705 - $105,481	427 Added 6.16%	7,363 $1.8 Million
Q3 2021 Oct 28, 2021	BUY	$189.29 - $209.69 $45,240 - $50,115	239 Added 3.57%	6,936 $1.35 Million
Q2 2021 Jul 28, 2021	SELL	$155.9 - $187.99 $12,939 - $15,603	-83 Reduced 1.22%	6,697 $1.25 Million
Q1 2021 Apr 23, 2021	BUY	$144.0 - $169.39 $74,160 - $87,235	515 Added 8.22%	6,780 $1.07 Million
Q4 2020 Feb 03, 2021	BUY	$157.07 - $174.35 $53,089 - $58,930	338 Added 5.7%	6,265 $1.04 Million
Q3 2020 Oct 30, 2020	BUY	$137.1 - $165.37 $86,784 - $104,679	633 Added 11.96%	5,927 $980,000
Q2 2020 Jul 31, 2020	BUY	$111.92 - $142.53 $174,259 - $221,919	1,557 Added 41.66%	5,294 $725,000
Q1 2020 May 05, 2020	BUY	$92.66 - $144.94 $137,507 - $215,090	1,484 Added 65.87%	3,737 $440,000
Q4 2019 Feb 11, 2020	BUY	$116.25 - $133.25 $16,158 - $18,521	139 Added 6.58%	2,253 $298,000
Q3 2019 Oct 30, 2019	BUY	$112.57 - $128.43 $237,972 - $271,501	2,114 New	2,114 $263,000
Q1 2018 May 07, 2018	SELL	$71.51 - $84.69 $16,089 - $19,055	-225 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$63.24 - $72.8 $1,897 - $2,184	30 Added 15.38%	225 $16,000
Q3 2017 Nov 13, 2017	BUY	$59.73 - $65.4 $11,647 - $12,753	195	195 $12,000

Others Institutions Holding ZTS

# of Institutions

1,897

Shares Held

423M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $87.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account